Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United StatesA Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 450
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07572929 - Phase 2Taking peopleTrial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
- Where
- Birmingham
- Age
- 18 years to 60 years
- People
- 29
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06315309 - Phase 1Taking peopleA Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Where
- Houston, Tampa
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06616636 - Phase 2Taking peopleTotal Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Where
- Duarte
- Age
- 18 years and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT07582172 - Phase 2Taking peopleFludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 270
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00801489 - Phase 1Taking peopleCPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 38
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03896269 - Phase 1/2Taking peopleAzacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Where
- Houston
- Age
- 18 years and over
- People
- 97
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04140487 - Phase 2/3Taking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Atlanta, Boston, Buffalo, Charleston, Columbus, Dallas, Durham, Hackensack, Houston, Los Angeles, Miami, Milwaukee, Mineola, Nashville, New Haven, New York, Orange, Portland, Salem, Seattle, The Bronx
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 1/2Taking peopleUnrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 37
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03173937 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 2Not yet taking people in United StatesAutomated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
- Where
- Palo Alto
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Stanford University
See details and how to joinNCT07634536 - Phase 1Taking peopleA Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Where
- Atlanta, Columbus, Duarte, Hackensack, Houston, Kansas City, Milwaukee, New York, Sacramento, Seattle, Stanford, Tampa
- Age
- 12 years to 78 years
- People
- 300
- Run by
- Orca Biosystems, Inc.
See details and how to joinNCT03802695 - No phaseTaking peopleCHIP/CCUS Natural History Protocol
- Where
- Bethesda
- Age
- 18 years to 99 years
- People
- 306
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT04102423 - Phase 1/2Taking peopleA Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06548230 - Phase 1Taking peopleRuxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Columbus, Dallas, Portland
- Age
- 18 years and over
- People
- 51
- Run by
- Jennifer Saultz
See details and how to joinNCT03874052 - Phase 2Taking peopleMetronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
- Where
- Richmond
- Age
- 18 years and over
- People
- 40
- Run by
- Virginia Commonwealth University
See details and how to joinNCT07710534 - Phase 1Taking peopleEdetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- Where
- Houston
- Age
- 1 year and over
- People
- 58
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03630991 - Phase 2Taking peopleDecitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
- Where
- Seattle
- Age
- 18 years and over
- People
- 25
- Run by
- University of Washington
See details and how to joinNCT04282187 - Phase 1Taking peopleCLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
- Where
- Seattle
- Age
- 18 years and over
- People
- 120
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04375631 - Phase 2Taking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Atlanta, Birmingham, Boston, Charleston, Chicago, Cleveland, Duarte, Hialeah, Houston, Los Angeles, New York, Phoenix, Salt Lake City, Stanford
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - Phase 2Taking peopleCo-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
- Where
- Cleveland
- Age
- 18 years and over
- People
- 36
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06904482 - Phase 1/2Taking peopleIvosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- Where
- Boston, Cleveland, Houston, Portland
- Age
- 18 years and over
- People
- 96
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03471260 - Phase 2Taking peopleEnasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03683433 - Phase 1/2Taking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Duarte, Houston, Milwaukee, Pittsburgh, Tampa
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00